Director, Global New Product Commercialization

Formulate early commercial strategy and approach for select pipeline programs; Develop target product profiles, serve as commercial voice for the asset in key governance forums Provide commercial input and strategic guidance to program teams to inform key business decisions on early-stage clinical programs. Collaborate cross-functionally to conduct rigorous market assessments on key disease areas to inform preclinical strategic planning. Understand and communicate requirements for reimbursement and differentiation to ensure successful global commercialization of pipeline assets. Identify gaps in internal understanding of target diseases and create detailed plans to address gaps through KOL engagement and primary market research. Inform the development of forecast assumptions for financial models. Bachelor's Degree in Life Sciences or equivalent required, MBA preferred Minimum 8 years of experience inclusive of market analytics, new product planning and global brand marketing Experience in at least one of ALNY's disease areas of focus (CNS, Hematology, Cardiovascular) preferred, Obesity experience required. Experience working cross-functionally, including collaboration with and influencing of program development team. Solid understanding of pharmaceutical development path and ability to identify operational choices that could impact commercialization. Ability to synthesize findings and clearly articulate implications from multiple sources of information, including primary and secondary market research and data, and formulate strong, supportable recommendations. Strong analytical skills, including the ability to forecast. Aptitude for understanding scientific concepts related to research and development. Strong oral and written communication and presentation skills